Cardiotoxicity
Cardiotoxicity means harmful effects on the heart. In discussions of ibogaine, it commonly refers to concern about heart rhythm effects and possible interactions with other health factors or substances; see also QT/QTc.
Plain-language reference
Ibogaine Glossary
A careful, alphabetized guide to common terms around ibogaine, iboga, research, cultural context, and safety language.
How to use this glossary
Start with the meaning, then the context.
This glossary is informational, not medical advice. Some words have a precise clinical meaning, while others are used in cultural, historical, or community settings where their meaning can be broader.
For a wider orientation to the subject, the Open Field 72 introduction to ibogaine provides background alongside this reference. Questions about terminology should not replace individualized medical or legal guidance.
Where a term points to risk, uncertainty, or regulation, the definition aims to say so directly rather than imply a treatment claim.
Alphabetized terms
Core plant and compound terms
These definitions distinguish the source plant, the isolated alkaloid, and the language commonly used to describe subjective effects. Labels such as “psychedelic” can be useful shorthand, but they do not settle questions of safety, legality, or clinical value.
C
D
Detox
“Detox” is an informal term often used for stopping a substance or managing withdrawal. In clinical settings, withdrawal management has a more specific meaning and may involve medical assessment; the term itself does not describe a particular outcome or establish safety.
E
Entheogen
Entheogen is a term used for substances in spiritual or religious contexts. It is not a clinical diagnosis or regulatory category, and cultural use of iboga should not be reduced to a pharmacological label alone.
I
Iboga
Iboga commonly refers to Tabernanthe iboga, a shrub native to Central West Africa. The plant has cultural and ceremonial significance in some communities, while scientific discussions often focus on alkaloids that may be isolated from plant material.
Ibogaine
Ibogaine is a naturally occurring alkaloid associated with iboga and related plants. It is often described as psychoactive and is not approved by the U.S. Food and Drug Administration for medical use; the FDA drug development and approval process explains why approval status is distinct from claims made about a substance.
M
Microdosing
Microdosing generally means taking a small amount of a psychoactive substance, often with the expectation of effects below the level of an overt experience. The word does not establish a standardized amount, verified benefit, or safety profile for ibogaine.
N
Noribogaine
Noribogaine is a metabolite formed when the body processes ibogaine. It is discussed in pharmacology because metabolites can have their own activity and duration; it should not be treated as interchangeable with ibogaine.
O
Oneirogen
Oneirogen means “dream-generating” and is sometimes used to describe substances associated with vivid dreamlike imagery. It is a descriptive term for experience, not a clinical classification, safety assessment, or evidence of therapeutic effect.
P
Psychedelic
Psychedelic is a broad label for substances that can alter perception, cognition, or sense of self. It is not synonymous with “safe” or “approved”; a general overview of the category appears in Wikipedia’s definition of psychedelic drugs.
Q
QT / QTc
QT is an interval measured on an electrocardiogram that relates to the heart’s electrical cycle; QTc is a version adjusted for heart rate. QT/QTc language appears in ibogaine safety discussions because changes in this measure can be relevant to rhythm risk; the National Heart, Lung, and Blood Institute’s arrhythmia overview provides general context on abnormal heart rhythms.
S
Supervised administration
This phrase usually means a substance is taken in the presence of another person or organization. It is not a universal legal or clinical standard, and the phrase alone does not demonstrate medical licensing, emergency readiness, screening quality, or suitability for an individual.
Context matters
Cultural, clinical, and legal language can overlap.
Terms around iboga and ibogaine are often carried between ceremonial settings, scientific literature, personal accounts, and commercial language. That movement can blur important distinctions. For example, “entheogen” may describe a spiritual frame, while “supervised administration” may sound clinical without defining a standard of care.
Regulatory status also varies by jurisdiction and can change. When comparing location-specific descriptions, resources discussing ibogaine in Mexico or the Bahamas context for ibogaine should be read with attention to the difference between local availability, legal status, and evidence of safety.
Clear terms do not remove uncertainty. They make it easier to recognize where uncertainty remains.
A careful reading process
01
02
03
Three checks for unfamiliar language
Identify the setting
Ask whether a term is being used in a cultural, legal, scientific, or marketing context. The same word can carry different assumptions in each setting.
Separate description from proof
Words such as “psychedelic,” “natural,” or “supervised” describe only part of a situation. They do not independently establish effectiveness, safety, or appropriateness.
Look for the missing detail
When a claim concerns opioid withdrawal or treatment, compare the language with a focused explanation of ibogaine and opioid treatment terminology and note what the claim does not say.
Common questions
Glossary notes for safer interpretation
Is ibogaine FDA-approved?
No. Ibogaine is not approved by the U.S. Food and Drug Administration for medical use. “Research,” “availability,” and “approval” are different terms, so they should not be used as if they mean the same thing.
Why do QT and QTc appear in ibogaine safety discussions?
QT and QTc refer to measurements on an electrocardiogram. Their appearance in safety discussions reflects concern about potential cardiac rhythm risk, not a treatment recommendation. The broader safety and risks overview keeps that context visible.
Does “natural” mean low risk?
No. A plant-derived origin does not resolve questions about dose, interactions, heart effects, product identity, or individual health factors. The term “natural” is descriptive, not a safety determination.
What is the difference between a facility and a center?
These are often organizational labels rather than standardized quality indicators. Descriptions of ibogaine treatment facilities and Canadian ibogaine treatment centers should be evaluated for what they explicitly document rather than the label alone.
Keep the language precise
Definitions are a starting point, not a substitute for care.
When a term is unclear, it is reasonable to ask whether it is cultural, scientific, legal, or promotional language—and what evidence supports the claim being made.